DBRG Q1 2026 Earnings EPS Misses Estimates by 39 Amid Challenging Market IBRX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress SEDG Q1 2026 Earnings EPS Miss by 50 Solar Market Headwinds Persist Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline Nordson NDSN Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower CTKB Q1 2026 Earnings EPS Misses Estimates as Operating Losses Widen